Case Illustration
Reducing 340B Compliance Risk While Protecting Margin
Project overview
Challenge:
Leadership faced growing concern over 340B audit exposure and margin erosion as regulatory scrutiny increased and data integrity issues surfaced across multiple systems.
What Was Happening:
Risk was accumulating silently. Fragmented data, unclear ownership, and reactive oversight left leadership exposed—without early warning indicators.
Cura’s Role:
- Performed a 340B risk and compliance diagnostic
- Mapped data flows across EMR, pharmacy, and billing systems
- Designed monitoring controls and exception reporting
- Aligned compliance efforts with financial performance goals
Outcome:
- Reduced audit exposure and compliance risk
- Improved confidence in 340B program integrity
- Protected critical margin supporting patient services
- Equipped leadership with early-visibility reporting
How Cura Helps:
We help organizations reduce hidden 340B risk while protecting margin through proactive controls, data visibility, and governance.
